The Stable Genius Report

• Major health insurance companies experienced substantial stock price increases after the implementation of Obamacare.
• UnitedHealth Group's stock price increased by 1177% from March 2010 to November 2025.
• Cigna's stock price increased by 822% from March 2010 to November 2025.
• Anthem/Elevance Health Inc.'s stock price increased by 414% from March 2010 to November 2025.
• Humana's stock price increased by 490% from March 2010 to November 2025.
• Molina's stock price increased by 859% from March 2010 to November 2025.
• Centene's stock price increased by 604% from March 2010 to November 2025.
• Aetna's stock price increased by 595% from March 2010 to 2018.

The post displays data concerning the stock performance of major health insurance companies, connecting their significant growth to the 'After Obamacare' period. This information, originating from a prominent political figure, contributes to the ongoing political discourse that can eventually influence the U.S. healthcare industry and, consequently, related companies within the S&P 500. While it presents historical and projected data rather than new policy announcements or immediate market catalysts, it highlights a narrative that could fuel future policy debates (e.g., reforms to the Affordable Care Act, increased regulation on insurance companies).

The post focuses exclusively on the domestic stock performance of U.S. health insurance companies and U.S. healthcare policy (Obamacare). It contains no references to international relations, foreign policy, military actions, or threats of global conflict.

• Commodities: Unlikely to have a direct impact. Gold (XAU) and Oil (WTI) are typically influenced by broader macroeconomic trends, geopolitical events, or supply-demand shocks, none of which are directly addressed in this post. The discussion on U.S. healthcare stock performance does not inherently create fear, inflation, or USD strength changes that would significantly move commodities. Short-Term Watchlist: N/A. Medium-Term Focus: N/A.
• Currencies (Forex): Minimal direct impact on the US Dollar Index (DXY). While U.S. domestic policy discussions can indirectly affect the dollar through broader economic sentiment or interest rate expectations, this post primarily presents data on a specific sector's performance under existing law, not a new policy or economic shock. Short-Term Watchlist: N/A. Medium-Term Focus: N/A.
• Global Equities: Primary impact, if any, would be concentrated within the U.S. healthcare sector (S&P 500 healthcare components). Limited direct impact on broader global equity indices like STOXX 600, Nikkei 225, or Hang Seng, as the post's content is specific to U.S. domestic policy and companies. Short-Term Watchlist: U.S. healthcare sector ETFs (e.g., XLV). Medium-Term Focus: Policy discussions impacting U.S. healthcare, potential for sector rotation if policy risks increase.
• Fixed Income (Bonds): Minimal direct impact on US 10Y and 2Y yields. The post does not signal an imminent change in monetary policy, inflation outlook, or a flight to safety scenario. Credit spreads for healthcare companies could see minor shifts if future policy risk intensifies, but not based on this data presentation alone. Short-Term Watchlist: N/A. Medium-Term Focus: N/A.
• Volatility / Derivatives: Unlikely to cause a significant spike in the VIX. The information presented is historical and projected financial data tied to a domestic policy, not a sudden shock event or a new, unforeseen risk to the broader market. Short-Term Watchlist: N/A. Medium-Term Focus: N/A.
• Crypto / Digital Assets: No direct impact. Bitcoin (BTC) and other digital assets typically react to broader risk sentiment, macro liquidity, or regulatory news specific to the crypto space, none of which are related to U.S. health insurance stock performance data. Short-Term Watchlist: N/A. Medium-Term Focus: N/A.
• Cross-Asset Correlations and Systemic Risk: No indications of systemic risk or breakdown in normal correlations. The post's content is too specific and contained to trigger broader market liquidity stress or margin calls. Short-Term Watchlist: N/A. Medium-Term Focus: N/A.
• Retail Sentiment / Market Psychology: Unlikely to directly trigger widespread retail speculation or a 'meme stock' phenomenon. The post is a data-driven critique of a policy's financial beneficiaries rather than a call to action for specific investments. Short-Term Watchlist: N/A. Medium-Term Focus: N/A.